BioDelivera

Programmable drug delivery precisely targets only diseased cells

BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time. BioDelivera has demonstrated efficacy in tumors, muscle, and brain and is expanding to additional tissues. The company’s mission is to enable cures for every patient, across every disease.

Category
Productivity
Pricing
freemium
Difficulty
beginner

Y Combinator batch: Fall 2026

Directory records are starting points for research. Check the official website for current features, pricing and availability. A catalog sync is not a hands-on product review.

Official website

Features

  • AI-Powered

Industries

  • Healthcare